Ishares Biotechnology Etf Market Value
| IBB Etf | USD 139.91 1.95 1.41% |
| Symbol | IShares |
The market value of iShares Biotechnology ETF is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is IShares Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Biotechnology's market value can be influenced by many factors that don't directly affect IShares Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
IShares Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IShares Biotechnology's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IShares Biotechnology.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in IShares Biotechnology on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding iShares Biotechnology ETF or generate 0.0% return on investment in IShares Biotechnology over 30 days. IShares Biotechnology is related to or competes with First Trust, Ultimus Managers, Horizon Kinetics, Harbor Health, American Beacon, First Trust, and Direxion Daily. The fund generally will invest at least 80 percent of its assets in the component securities of its index and in investm... More
IShares Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IShares Biotechnology's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess iShares Biotechnology ETF upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 6.56 | |||
| Value At Risk | (1.70) | |||
| Potential Upside | 1.55 |
IShares Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IShares Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IShares Biotechnology's standard deviation. In reality, there are many statistical measures that can use IShares Biotechnology historical prices to predict the future IShares Biotechnology's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | (0.1) |
iShares Biotechnology ETF Backtested Returns
iShares Biotechnology ETF holds Efficiency (Sharpe) Ratio of -0.0673, which attests that the entity had a -0.0673% return per unit of risk over the last 3 months. iShares Biotechnology ETF exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out IShares Biotechnology's Risk Adjusted Performance of (0.05), market risk adjusted performance of (0.09), and Standard Deviation of 1.12 to validate the risk estimate we provide. The etf retains a Market Volatility (i.e., Beta) of 0.97, which attests to possible diversification benefits within a given portfolio. IShares Biotechnology returns are very sensitive to returns on the market. As the market goes up or down, IShares Biotechnology is expected to follow.
Auto-correlation | -0.31 |
Poor reverse predictability
iShares Biotechnology ETF has poor reverse predictability. Overlapping area represents the amount of predictability between IShares Biotechnology time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of iShares Biotechnology ETF price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current IShares Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.31 | |
| Spearman Rank Test | -0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 23.04 |
iShares Biotechnology ETF lagged returns against current returns
Autocorrelation, which is IShares Biotechnology etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting IShares Biotechnology's etf expected returns. We can calculate the autocorrelation of IShares Biotechnology returns to help us make a trade decision. For example, suppose you find that IShares Biotechnology has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
IShares Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If IShares Biotechnology etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if IShares Biotechnology etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in IShares Biotechnology etf over time.
Current vs Lagged Prices |
| Timeline |
IShares Biotechnology Lagged Returns
When evaluating IShares Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of IShares Biotechnology etf have on its future price. IShares Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, IShares Biotechnology autocorrelation shows the relationship between IShares Biotechnology etf current value and its past values and can show if there is a momentum factor associated with investing in iShares Biotechnology ETF.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether iShares Biotechnology ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Biotechnology Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Biotechnology Etf:Check out IShares Biotechnology Correlation, IShares Biotechnology Volatility and IShares Biotechnology Alpha and Beta module to complement your research on IShares Biotechnology. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
IShares Biotechnology technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.